000 | 01657 a2200409 4500 | ||
---|---|---|---|
005 | 20250517023456.0 | ||
264 | 0 | _c20150703 | |
008 | 201507s 0 0 eng d | ||
022 | _a1524-4636 | ||
024 | 7 |
_a10.1161/ATVBAHA.115.305085 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRizzo, Alicia N | |
245 | 0 | 0 |
_aTargeting Abl kinases to regulate vascular leak during sepsis and acute respiratory distress syndrome. _h[electronic resource] |
260 |
_bArteriosclerosis, thrombosis, and vascular biology _cMay 2015 |
||
300 |
_a1071-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aBenzamides _xadministration & dosage |
650 | 0 | 4 |
_aCapillary Permeability _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImatinib Mesylate |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMolecular Targeted Therapy _xmethods |
650 | 0 | 4 |
_aPiperazines _xadministration & dosage |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-abl _xdrug effects |
650 | 0 | 4 |
_aPyrimidines _xadministration & dosage |
650 | 0 | 4 |
_aRespiratory Distress Syndrome _xdrug therapy |
650 | 0 | 4 |
_aSepsis _xdrug therapy |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aAman, Jurjan | |
700 | 1 | _avan Nieuw Amerongen, Geerten P | |
700 | 1 | _aDudek, Steven M | |
773 | 0 |
_tArteriosclerosis, thrombosis, and vascular biology _gvol. 35 _gno. 5 _gp. 1071-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1161/ATVBAHA.115.305085 _zAvailable from publisher's website |
999 |
_c24747637 _d24747637 |